IBB/SPY ratio shows fantastic base in IBB/SPY from 2001 to 2012 ("bigger the base, the higher in space") with a huge breakout in early 2012 to recent highs in March 2015. But (and there's always a but), IBB/SPY exceeded channel (highlighted) last month and shows bearish
negative divergence. Biotechs have been the "it" sector/niche in this bull
market...now that it's showing weakness, what does that portend for greater market?
Good time to take profits in biotechs and go short?